Tag: covid19

  • COVID-19 Claims Trends: International Health Insurance (Aetna)

    COVID-19 Claims Trends: International Health Insurance (Aetna)

    Aetna International, one of the leading International Health Insurance providers, hosted their first virtual conference last week to their key partners.

    As well as being a great day and a chance to connect with the Aetna International team, we were provided updates on claims trends being seen during COVID-19 as well as details on how Aetna are working to simplify and improve member resources for their International Health Insurance members.

    Key updates

    • Donal O’Leary, Vice President International Actuarial & Underwriting, talked us through Aetna’s commercial experience to date and their view of the situation moving forward.
    • COVID-19 presents a complex and moving picture when it comes to assisting the commercial impact on the International Health Insurance market.
    • Firstly, in a pandemic situation there is ultimately a finite exposure as there is only a certain number of private beds and treatments available. There are a few factors that vary the impact seen as the pandemic rolls through over time and in difference regions;
      • Chronic conditions – it is still unclear which chronic conditions will develop and linger on after the initial illness and we are unlikely to fully understand this impact for a year
      • How long the pandemic lasts for – clearly the longer the situation goes on for, the higher the commercial exposure
      • Government support – This varies greatly by region and can also fluctuate, however good levels of government support allows firms to maintain benefits and staffing levels, holding up the revenue line.
    • The claims experience has varied significantly between countries with some markets experiencing significantly depressed claims for the first half of 2020, but others less so. Elective treatments have had the largest drop in March and April and are now returning to normal levels in markets initially heavily impacted.
    • Asia and the EMEA (Europe Middle East & Africa) regions have experienced the largest impact in H1 and this has driven some key learning;
      • Between March and May Aetna were seeing the stockpiling of medicines, what would usually be a 30 day prescription was coming in as a 90 day prescription,
      • The claims mix changes with less small claims, however more serious, high cost claims were less suppressed, particularly for cancer, heart conditions, strokes etc.
      • There has been some evidence of providers looking to recoup some of their losses via overcharging, an example given was a Russian hospital looking to charge for a CT scan for routine dental work. Their teams are now particularly vigilant to ensure they pick up this type of behaviour.
      • Evacuation benefit is included in all of Aetna’s International Health Insurance plans and these costs have been the main unplanned increase. Usually evacuations would be a mix of commercial flights and specialised medical transport which is much more expensive. Due to the lockdown of main countries, medical transport has been one of the only ways to move patients driving a significant increase in the use of private jets and a spoke in claims cost.
    • Aetna hasn’t experienced any bad debt yet, however if there is a second wave them government support will play a large pat in if that continues to be the case.
    • While claims have been lower, they aren’t as low as they had expected due to the reasons outlined above.
    • In the 2nd half of the year there is an increasing financial risk as delayed treatments catch up, although this may be a fairly smooth increase as people will still be anxious about going to some hospitals.
    • Supporting the increase in claims in H2 will be the adjustments that private hospitals have made in the last few months are initially being caught cold by the virus. They have now successfully introduced social distancing and introduced safe practises to be able to reopen within the current rules and well as significantly increase virtual client support.
    • Aetna expect there will be a significant increase in testing this winter as symptoms of common cold and flu are confused with COVID-19.
    • Aetna’s V health Virtual Doctor solution has, as you would expect seen an increase of almost 800% since global lockdown’s were put in place. This is partly fuelled by their decision to offer this to all of their members, whether it was originally included in their International Health Insurance plan.
    • Aetna expect this to drop off as lockdown’s ease, however they expect this to stay much higher than it was previously as the NPS score and feedback from the service has been so positive, so they foresee a behaviour change moving forward.
    • In EMEA Aetna have been providing premium credits to community rated SME clients to reflect the reduction in claims between April and June. They are committed to dealing with this as fairly as possible and pass back any profits they were not planned to make.
    • Aetna is focused on long term pricing sustainability and supporting their client relationships at this time.
    • For larger experienced rated groups they will be deducting April – June form the experience for that year and looking tin introduce profit shares to pass back unplanned profit.

     

    To round off…

    The experience has varied by country and Aetna haven’t experienced the drop in claims that they would have expected to, given the lockdowns in place, this has been driven by the broadly stable serious health claims and a spike in evacuation cost. Aetna are committed to not making any financial gains from the pandemic and will pass back any additional profits they make.

    Engage International is the specialist International team at Engage Health Group, supporting expatriates and high net worth clients with International Health Insurance, as well as offering a full range of broking and consultancy for businesses with an international footprint. 

    If you have any International health Insurance needs or which to discuss this article, or the broader International Employee Benefits market in further detail please get in touch.

  • Coronavirus – Is your Health Insurance Covered? We look at the different Health Insurance Companies

    Coronavirus – Is your Health Insurance Covered? We look at the different Health Insurance Companies

    As you might expect, we are experiencing a significant number of enquiries from customers asking whether their health insurance policy covers any element of the recent COVID-19 outbreak…

    The answer here is not always a straightforward one and depends on which insurer you’re with, and in which region of the world you are covered.  International Private Medical Insurance (IPMI) offers a greater degree of cover by its very nature, but the stance can still differ significantly.

    All major UK health insurers are holding the same position: That those diagnosed with COVID-19 will be best looked after within the NHS, as they are better equipped to manage these patients in isolation.  Any patients testing positive would likely be within an NHS clinic or hospital for monitoring and/or temporary relief of symptoms as opposed to active treatment typically available under UK PMI plans.

    That said, it’s expected that a small number of patients could develop more severe complications as a result, such as pneumonia, which would be covered by their health insurance plan in most cases. Whilst they couldn’t be moved to a private hospital or facility, most health insurers will consider applications for NHS cash benefit (where the option is included on their plan), but this may be on a case-by-case basis. 

    Now that the World Health Organisation (WHO) has declared COVID-19 to be a pandemic disease, this can also change how an insurer will treat a potential claim, as some insurers have general scheme exclusions for pandemic diseases. 

    We have provided a breakdown below:

     

    Domestic (UK) Health Insurance Companies / Providers

    AXA – No exclusions for pandemic diseases and may offer NHS cash benefit where applicable

    Bupa – Pandemics are a standard scheme exclusion so no cover available

    Cigna – Would consider NHS cash benefit and related conditions for cover

    Freedom – Pandemics are a standard scheme exclusion so no cover for this or related conditions

    PHC – No cover for Coronavirus, related conditions or NHS cash benefit

    Vitality – COVID-19 classed as “Emergency Treatment” and thus excluded from cover. Will consider NHS cashback for related eligible conditions.

    WPA – No exclusions for pandemics and will offer NHS cash benefit where applicable

     

    International Health Insurance Companies / Providers

    Aetna – No exclusions for pandemics and Coronavirus is covered

    AXA Global – Healthcare benefits will apply as normal if members are diagnosed with Coronavirus

    Bupa Global – Does have an exclusion for epidemics and pandemics but currently, this isn’t being enforced and they are covering Coronavirus at their discretion.

    Cigna – No exclusion for pandemics and Coronavirus is covered

    Generali – Does have an exclusion for epidemics and pandemics but currently this isn’t being enforced and they are covering Coronavirus.

    Now Health – There is no exclusion for pandemics and Coronavirus is covered

    William Russell – Members are covered in the same way as they would be for any viral infections

    All insurers are within their rights to deny claims if customers have travelled against the advice of the Foreign & Commonwealth Office travel advice.

     

    Engage Health Group has made every effort to ensure the accuracy of this information having spoken with its insurer partners, but as the situation is changing regularly, it is recommended that customers contact their insurer directly with any specific questions.

    If you have any questions or would like to find out more, please get in touch.